Download presentation
Presentation is loading. Please wait.
Published byClarissa Wiggins Modified over 5 years ago
1
Advances and highlights in mechanisms of allergic disease in 2015
Paulina Wawrzyniak, MSc, Cezmi A. Akdis, MD, Fred D. Finkelman, MD, Marc E. Rothenberg, MD, PhD Journal of Allergy and Clinical Immunology Volume 137, Issue 6, Pages (June 2016) DOI: /j.jaci Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
2
Fig 1 Role of cells and cytokines in allergic airway diseases. Epithelial cells are activated by external factors, such as allergens and viruses. IL-33 secreted from epithelial cells acts on mast cells and ILC2s, which results in a predominantly IL-13–regulated gene expression (Nagarkar et al108). During the development of fibrosis, bleomycin induces IL-33 release by epithelial cells and stimulates a neutrophil-dependent processing of IL-33. IL-33 stimulates the production of IL-13 by ILC2s and macrophages and the production of TGF-β by macrophages. This currently acts as a major mechanism in the development of lung fibrosis (Li et al110). IL-9 secreted by TH9 cells is apparently important for the accumulation and activation of mast cells in the lungs (Sehra et al109). Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
3
Fig 2 Mechanisms of allergen-specific immunotherapy. Allergen-specific immunotherapy induces Treg and regulatory B (Breg) cells. As a consequence, peripheral tolerance is induced, which in term regulates the effector cells of allergy, in various ways. Treg cells suppress TH2 cells and their cytokine production, which are indispensable for the differentiation, survival, and activity of mast cells, basophils, eosinophils, and mucus-producing cells and for tissue homing of TH2 cells. IL-10 and TGF-β suppress IgE production, while inducing IgG4, a noninflammatory immunoglobulin isotype. Allergen-specific Breg cells are characterized by high IL-10, CD25, programmed cell death 1 ligand 1 (PD-L1), GARP, IL-1 receptor antagonist (IL-1ra), and vascular endothelial growth factor (VEGF) expression. DC, Dendritic cell; SOC3, suppressor of cytokine signaling 3. Journal of Allergy and Clinical Immunology , DOI: ( /j.jaci ) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.